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Introduction 
Syncope is a sudden transient loss of consciousness and 
postural tone with spontaneous recovery.  Loss of 
consciousness results from a reduction of blood flow to 
the reticular activating system located in the brain stem. 
Syncope is an important clinical problem which accounts 
for 1% of hospital admissions and 3% of emergency 
department visits with a reported mortality and major 
morbidity rate of over 7% [1]. It is often disabling, may 
cause injury and may be the only warning sign before 
sudden cardiac death. The prognosis of patients with 
syncope varies greatly with the underlying etiology. 
 
Causes of Syncope 
Syncope is a symptom, not a disease, and can be 
classified according to the underlying cause. The causes of 
syncope can be classified into six groups including 
vascular, cardiac, neurological, psychogenic, metabolic, 
and syncope of unknown origin. Vascular causes of 
syncope (Table 1) are most common, followed by cardiac 
causes of syncope (Table 2). The most common cause of 
syncope in the general population is the neurally- 
mediated syncope (also known as neurocardiogenic, 
vasovagal syncope and as “fainting”), followed by primary 
cardiac arrhythmias. 
 
The causes of syncope are highly age dependent [2]. 
The etiology of syncope in children and young adults is 
most likely related to neurocardiogenic syncope, 
psychiatric conversion reactions, and primary arrhythmic 
causes such as Wolff-Parkinson-White (WPW) syndrome 
and long QT interval syndrome (LQTS). 
 
In middle age, neurocardiogenic syncope remains the 
most frequent cause of syncope. 
 
Common causes of syncope in elderly persons include 
orthostatic hypotension, postprandial hypotension, 
medications, aortic valve stenosis, carotid sinus 
hypersensitivity, and bradyarrhythmias (e.g. sick sinus 
syndrome, heart block). 
 
Other forms of neurocardiogenic syncope (so-called 
situational syncope) related to deglutition, micturition, 
defecation, and cough are more common in the middle-
aged or elderly patients than in young patients [3].  
 
Metabolic causes of syncope are rare, accounting for 
less than 5% of syncopal episodes. The most common 
metabolic causes of syncope are hypoglycemia, hypoxia, 
and hyperventilation. 
 
 
 
 
Pathophysiology 
Neurocardiogenic syncope is caused by an abnormal or 
exaggerated autonomic response to various stimuli, such 
as standing and emotion. The mechanism is poorly 
understood but involves reflex mediated changes in heart 
rate or vascular tone, caused by stimulation of the 
medullary vasodepressor region of the brain stem. 
Stimulation of this region in the brain may occur due to 
activation of various receptors, such as the afferent 
mechanocardiac receptors (cardiac C fibers), 
cardiopulmonary baroreceptors, gastrointestinal or 
genitourinary mechano-receptors [4,5]. When a person 
stands, 500 to 800 ml of blood is displaced to the 
abdomen and lower extremities, resulting in an abrupt 
drop in venous return to the heart. This drop leads to a 
decrease in cardiac output and stimulation of aortic, 
carotid, and cardiopulmonary receptors, which trigger a 
reflex increase in sympathetic outflow. As a result, heart 
rate, cardiac contractility, and vascular resistance increase 
to maintain a stable systemic blood pressure on standing. 
 
In patients susceptible to neurocardiogenic syncope, the 
reduction in ventricular preload (due to venous pooling) 
and increased catecholamine levels lead to a vigorously 
contracting volume-depleted ventricle. It has been 
proposed that vigorous contractions of a volume-depleted 
ventricle lead to activation of the cardiac C fibers 
(nonmyelinated fibers, found in the atria, ventricles and 
pulmonary artery).  Stimulation of these afferent C fibers 
leads to a “paradoxical” withdrawal of peripheral 
sympathetic tone and an increase in vagal tone, which, in 
turn causes vasodilation and bradycardia. The ultimate 
clinical consequence is syncope or presyncope [1]. 
 
Cardiac arrhythmias are an important cause of 
neurologic symptoms. Bradyarrhythmia and 
tachyarrhythmia may cause syncope by disrupting blood 
flow to the brain. 
 
Clinical Features 
Although presentation of neurocardiogenic syncope is 
similar to that of other types of syncope, loss of 
consciousness in patients with neurocardiogenic syncope 
may be preceded by prodromata such as nausea, 
diaphoresis, lightheadedness, ringing in the ears, blurred 
vision, headaches, palpitations, paraesthesia, and pallor 
[6,7]. 
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Key clinical features of neurocardiogenic syncope  
- It tends to be situational. 
- It is often recurrent during a patient’s lifetime. 
- It is often preceded by at least a few seconds of 
prodromal symptoms. 
- It occurs when the patient is in the upright position, 
and is resolved and can be aborted by assuming the 
supine position. 
- After recovery, patients with neurocardiogenic syncope 
often complain of a “washed out” and tired feeling. 
 
Although neurocardiogenic syncope can be seen in any 
age group, it is most common in younger patients with 
normal cardiac function. It tends to be uncommon in 
patients with significant cardiac dysfunction, probably 
because the C fibers are affected by myocardial disease 
[4]. 
 
Syncope associated with high intensity physical activity 
is a typical presentation of hypertrophic cardiomyopathy or 
catecholaminergic ventricular tachycardia. 
 
Table 1  Causes of vascular syncope 
Orthostatic Reflex-mediated 
Autonomic insufficiency 
Idiopathic 
Hypovolemia 
 Drug-induced 
Carotid sinus hypersensitivity 
Neurally mediated syncope 
Glossopharyngeal syncope 
Situational (cough, micturition) 
Adenosine sensitive      
 
Table 2  Cardiac causes of syncope 
Structural Arrhythmogenic 
Aortic valve stenosis. 
Aortic dissection. 
Atrial myxoma. 
Hypertrophic 
cardiomyopathy. 
Cardiac tamponade. 
Myocardial infarction. 
Pulmonary embolism. 
Pulmonary hypertension. 
Bradyarrhythmia: 
     - Sinus node dysfunction. 
     - AV-block. 
Tachyarrhythmias: 
     - Supraventricular 
arrhythmias. 
     - Ventricular arrhythmias. 
 
Table 3  Features of clinical history distinguishing seizures 
from syncope 
Confusional state following the event (postictal state). 
Blue face (not becoming pale) during the event. 
Frothing at the mouth. 
Aching muscles. 
Feeling sleepy after the event. 
Duration of unconsciousness of more than 5 minutes. 
Tongue biting (strongly suggestive of a seizure). 
An aura before the episode. 
Horizontal eye deviation during the episode. 
Elevated BP and pulse during the episode. 
A headache following the event. 
Tonic-clonic movements (may also occur in cardiac 
syncope). 
Diagnostic Evaluation of Syncope 
The primary purpose of evaluating patients with 
syncope is to determine whether the patient is at 
increased risk of death. This involves identifying patients 
with underlying heart disease and potentially life-
threatening arrhythmias. 
 
1- History and Physical Examination 
In most patients, the cause of syncope can be 
determined with great accuracy from a careful history and 
physical examination. The history is also useful for 
identifying precipitating factors that may increase risk of 
syncope [8]. Assessment of the symptoms and the clinical 
setting may yield clues as to the possible cause of the 
syncope. 
 
Syncope after cough, defecation, and micturition 
suggests situational syncope; and syncope after pain, fear, 
or noxious stimuli suggests neurocardiogenic syncope [5]. 
Carotid sinus syncope may occur with rotation or turning 
of the head or pressure on the carotid sinus (for example, 
carotid massage, shaving, tight collars or neckwear). 
History of tonic-clonic seizure-like activity is associated 
with both cardiac and neurological causes of syncope [6]. 
 
Auras, premonitions, postictal confusion, and focal 
neurological signs and symptoms suggest a neurological 
cause of syncope (Table 3). 
Episodes of neurocardiogenic syncope are typically 
associated with post-episode fatigue and weakness, 
whereas the absence of a prodrome is consistent with 
cardiac syncope [9]. 
 
Vertebral basilar insufficiency should be considered as 
the cause of syncope if syncope occurs in association with 
other symptoms of brainstem ischemia such as diplopia, 
tinnitus, focal weakness or sensory loss, vertigo or 
dysarthria. 
 
A history of myocardial infarction or previously repaired 
congenital cardiac defect raises the possibility of 
ventricular arrhythmias. 
 
It is also useful to obtain careful history from witnesses 
who may have been present during the episode of 
syncope. 
 
A careful physical examination is extremely useful in the 
evaluation of syncope. Orthostatic hypotension, autonomic 
dysfunction, and some cardiac defects can be identified by 
measuring blood pressure and pulse rate in the upper and 
lower extremities both in supine and upright positions. 
Carotid bruits should raise the possibility of compromised 
cerebral blood flow and underlying carotid artery disease. 
Abnormalities of visual fields, speech, motor strength, and 
sensation, tremor, and gait disturbances suggest an 
underlying neurological disorder. 
 
Physical examination may suggest the presence of 
pulmonary hypertension, left ventricular dysfunction, 
valvular heart disease, or other forms of structural heart 
disease. 
 
2- The electrocardiogram (ECG) 
The ECG provides important information about the 
cardiac rhythm and the atrioventricular (AV) conduction. 
Specific findings that can identify the probable cause of 
syncope include QT prolongation (LQTS), the presence of 
a short PR interval and delta waves (WPW syndrome), the 
presence of a right bundle branch block and ST segment 
elevation (Brugada syndrome), evidence of an acute 
myocardial infarction, or inverted T waves in the right 
precordial leads (arrhythmogenic right ventricular 
dysplasia).  
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3- Echocardiography 
 It is an excellent tool to identify underlying structural 
heart disease, including valvular heart disease and 
cardiomyopathies. 
 
4- Exercise stress 
It should be performed in patients with unexplained 
syncope, especially if the episode was related to exertion. 
This test provides the opportunity to monitor pulse and 
blood pressure (BP) responses to exercise. A drop of BP or 
failure of BP to rise in response to exercise raises the 
question of severe coronary artery disease or hypertrophic 
obstructive cardiomyopathy. 
 
5- Noninvasive ambulatory ECG monitoring 
It allows for the diagnosis of cardiac rhythm 
disturbances and the correlation of symptoms with the 
cardiac rhythm. The type and duration of ambulatory ECG 
monitoring is dictated by the frequency of symptoms. The 
gold standard for the diagnosis of an arrhythmic cause of 
syncope is ECG documentation of the rhythm disturbances 
at the time of symptoms. 
 
6- Tilt table testing (TTT) 
This is a useful test in establishing the diagnosis of 
neurocardiogenic syncope. A positive TTT (i.e. a study 
that reproduces the patient’s syncope) identifies a patient 
who is prone to neurocardiogenic syncope [4]. 
Nevertheless, there have been serious questions about the 
sensitivity, specificity and diagnostic yield of this test 
[11,12]. 
 
In a patient of any age with an otherwise normal 
evaluation who has a negative TTT, the most likely 
diagnosis is still neurocardiogenic syncope. In patients 
with a malignant episode of syncope, it may be more 
important to rule out other causes of syncope such as 
cardiac arrhythmias than it is to perform a TTT. 
 
7- Electrophysiological testing (EPS) 
It involves placement of Transvenous catheters/wires 
within the heart to assess sinus node function, AV 
conduction, and susceptibility to supraventricular and 
ventricular tachycardias. Invasive EP testing is indicated in 
syncopal patients who are found to have a previous 
myocardial infarction, poor left ventricular function (left 
ventricular ejection fraction of less than 40%), or 
nonsustained ventricular tachycardia.  
Approximately 30% of patients with syncope referred 
for EPS to evaluate syncope of unknown origin have a 
presumptive diagnosis established. A negative EPS has 
generally been considered predictive of a low risk of 
sudden death. In patients with an otherwise normal 
evaluation for syncope, the yield of EPS is low 
(approximately 3%) and, therefore, this test is not 
routinely recommended [13]. 
 
8- Neurological Evaluation 
Syncope as an isolated symptom rarely has a 
neurological cause. Neurological causes of syncope are 
established in less than 5% of patients with syncope.   
Neurological causes of syncope should be pursued only if 
suggested by history or physical examination. 
 
Seizure disorders are the most common neurological 
cause of episodic unresponsiveness. An 
electroencephalogram can confirm seizure disorders.  It 
must be noted here that cardiac syncope can be 
accompanied by upward gaze deviation, asynchronous 
myoclonic jerks, and brief automatisms that result from 
global cerebral hypoperfusion and are not an indication for 
a neurological evaluation. 
 
Focal neurological signs such as diplopia, limb 
weakness, sensory deficits, or speech difficulties are 
indications for a neurological evaluation. Current 
guidelines for the evaluation of syncope suggest that EEGs 
be only obtained when there is a relatively high likelihood 
of seizure disorder. CT and magnetic resonance imaging 
(MRI) should be avoided in patients with uncomplicated 
syncope [14]. 
 
Treatment
The approach to treatment of a patient with syncope 
depends largely on the diagnosis (cause) that is 
established.  In the elderly, multiple causes of syncope 
frequently coexist and need to be addressed. Emphasis 
should be given to the impact of polypharmacy, 
orthostatic intolerance, autonomic dysfunction, and carotid 
sinus hypersensitivity, particularly in elderly patients. 
 
1- Syncope in the patient with a normal Evaluation 
Although many life-threatening clinical entities are less 
likely in the presence of a normal evaluation, the 
possibility of neurocardiogenic syncope, carotid sinus 
hypersensitivity, paroxysmal bradyarrhythmias and 
tachyarrhythmia and myriad noncardiac causes of syncope 
remains [3]. 
 
In the absence of underlying heart disease, syncope is 
not associated with excess mortality. The main risk is 
related to physical harm that may occur if the patient has 
recurrent syncope. 
 
The mainstay of management of patients with 
neurocardiogenic syncope is education of the patient to 
avoid situations that predispose to syncope (e.g., 
dehydration, stress, alcohol consumption, prolonged 
standing, and extremely warm environments). This should 
also include anxiety management and coping skills, and 
reassuring the patient that this is a benign condition. 
 
It has been found that the administration of beta-
blockers or disopyramide is often effective in preventing 
neurocardiogenic syncope [15]. Although it may seem 
paradoxic to prescribe beta blockers for patients whose 
syncope is often accompanied by significant bradycardia, 
using beta blockers makes sense when one considers that 
hypersympathetic tone is necessary to engage the cardiac 
C fibers. Disopyramide has a strong vagolytic effect, but 
more importantly, it has a direct negative inotropic effect 
on the heart, presumably inhibiting C fiber stimulation. It 
is not considered first line treatment because of the risk of 
proarrhythmic and anticholinergic adverse effects.   
Midodrine, an alpha agonist, has been shown to be 
effective in several randomized trials. 
 
In most patients with neurocardiogenic syncope, a fall in 
blood pressure precedes bradycardia; therefore, cardiac 
pacing is often ineffective in most patients. However, dual 
chamber pacing may be effective in reducing symptoms if 
there is a large cardioinhibitory component [7]. 
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2- Syncope in the patient with cardiac disease 
Syncope in patients with underlying heart disease is 
associated with a high rate of mortality.                                                                  
 
The appropriate treatment for patients with syncope 
related to advanced AV block or sick sinus syndrome is 
permanent pacing. The treatment of a patient with 
syncope related to WPW syndrome would probably involve 
catheter ablation of the accessory pathway. 
 
Treatment of patients with syncope related to 
ventricular tachycardia and underlying ischemic 
cardiomyopathy would probably involve placement of an 
implantable cardioverter defibrillator (ICD) and/or 
revascularization. Implantable defibrillator therapy is also 
effective in high-risk patients with hypertrophic 
cardiomyopathy [16], nonischemic dilated 
cardiomyopathy, long QT syndrome [17], Brugada 
syndrome and in patients with arrhythmogenic right 
ventricular dysplasia [18]. Treatment of patients with 
syncope related to critical aortic valve stenosis would 
involve aortic valve replacement with or without coronary 
revascularization. 
 
Conclusion
Syncope is an important clinical problem and is 
associated with considerable morbidity. Neurocardiogenic 
syncope is the most common cause of syncope and is 
generally considered a benign condition, although 
frequent and recurrent episodes can negatively affect 
quality of life.  Syncope can be a precursor to sudden 
death, particularly in patients with underlying heart 
disease. Therefore, the primary purpose of the evaluation 
of the patient with syncope should be to determine 
whether the patient is at increased risk for death. This 
involves identifying patients with underlying heart disease 
and potentially life-threatening arrhythmias. 
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